AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp

Last | 05/14/21 BST

7,864.00

+12.00 (+0.15%)

52 week range

6,736.00 - 10,120.00

...

Loading . . .

Open7,880.00
Day High7,882.00
Day Low7,825.00
Prev Close7,852.00
52 Week High10,120.00
52 Week High Date07/20/20
52 Week Low6,736.00
52 Week Low Date03/03/21

Key Stats

Market Cap145,604.98M
Shares Out1,312.74M
10 Day Average Volume1.89M
Dividend216.00
Dividend Yield2.75%
Beta0.19
YTD % Change7.37

KEY STATS

Open7,880.00
Day High7,882.00
Day Low7,825.00
Prev Close7,852.00
52 Week High10,120.00
52 Week High Date07/20/20
52 Week Low6,736.00
52 Week Low Date03/03/21
Market Cap145,604.98M
Shares Out1,312.74M
10 Day Average Volume1.89M
Dividend216.00
Dividend Yield2.75%
Beta0.19
YTD % Change7.37

RATIOS/PROFITABILITY

EPS (TTM)220.00
P/E (TTM)35.75
Fwd P/E (NTM)-
EBITDA (MRQ)-
ROE (MRQ)-
Revenue (MRQ)-
Gross Margin (MRQ)-
Net Margin (MRQ)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date02/25/2021
Div Amount137.40
Split Date-
Split Factor-

Latest On AstraZeneca PLC

The Seychelles is the most vaccinated nation on Earth. But Covid has surgedMay 13, 2021CNBC.com
Mix and match Covid vaccine study finds increased risk of adverse reactionsMay 12, 2021CNBC.com
Stocks making the biggest moves premarket: Marriott, Coty, BioNTech, Tyson FoodsMay 10, 2021CNBC.com
WHO urges world to follow U.S. and support waiving Covid vaccine patent protectionsMay 7, 2021CNBC.com
UK to offer under-40s alternative to AstraZeneca Covid-19 vaccineMay 7, 2021CNBC.com

Latest From Our Partners

COVID-19 vaccine co-inventor Vaccitech's stock pops 13% to top IPO price for first timeMay 14, 2021Seeking Alpha
Delaying second Pfizer COVID-19 shot boots antibodies more than three-fold in elderly, U.K. study findsMay 14, 2021Seeking Alpha
Mix and match COVID-19 vaccine study indicate higher risk of mild/ moderate symptomsMay 13, 2021Seeking Alpha
2 Hyper-Growth Blue Chips For A Rich RetirementMay 13, 2021Seeking Alpha
AstraZeneca urged by EU to deliver 120 million COVID-19 vaccine doses by end of JuneMay 11, 2021Seeking Alpha

Profile

AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...

Leif Johansson

Non-Executive Chairman

Pascal Soriot

Chief Executive Officer

Marc Dunoyer

Chief Financial Officer

Ruud Dobber

Executive Vice President

Menelas Pangalos

Executive Vice President

Address

1 Francis Crick Avenue

Cambridge

CB2 0AA

United Kingdom

https://www.astrazeneca.com/Home